Proteomic Analyses Identify Differentially Expressed Proteins and Pathways Between Low-Risk and High-Risk Subtypes of Early-Stage Lung Adenocarcinoma and Their Prognostic Impacts.

Zhou, Juntuo; Liu, Bing; Li, Zhongwu; Li, Yang; Chen, Xi; Ma, Yuanyuan; Yan, Shi; Yang, Xin; Zhong, Lijun; Wu, Nan

Proteomic Analyses Identify Differentially Expressed Proteins and Pathways Between Low-Risk and High-Risk Subtypes of Early-Stage Lung Adenocarcinoma and Their Prognostic Impacts.

Zhou, Juntuo; Liu, Bing; Li, Zhongwu; Li, Yang; Chen, Xi; Ma, Yuanyuan; Yan, Shi; Yang, Xin; Zhong, Lijun; Wu, Nan.

Afiliación

Zhou J; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Thoracic Surgery II, Peking University Cancer Hospital & Institute, Beijing, China; Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, Beihang University, Beijing, China.
Liu B; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Thoracic Surgery II, Peking University Cancer Hospital & Institute, Beijing, China.
Li Z; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital & Institute, Beijing, China.
Li Y; Department of Pathology, Peking University Health Science Center, Beijing, China.
Chen X; Department of Pathology, Peking University Health Science Center, Beijing, China.
Ma Y; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Thoracic Surgery II, Peking University Cancer Hospital & Institute, Beijing, China.
Yan S; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Thoracic Surgery II, Peking University Cancer Hospital & Institute, Beijing, China.
Yang X; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital & Institute, Beijing, China.
Zhong L; Center of Medical and Health Analysis, Peking University Health Science Center, Beijing, China. Electronic address: zhonglijun@bjmu.edu.cn.
Wu N; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Thoracic Surgery II, Peking University Cancer Hospital & Institute, Beijing, China. Electronic address: nanwu@bjmu.edu.cn.

Mol Cell Proteomics ; 20: 100015, 2021.

Article en En | MEDLINE | ID: mdl-33508502

Asunto(s)

Adenocarcinoma del Pulmón/metabolismo; Biomarcadores de Tumor/metabolismo; Neoplasias Pulmonares/metabolismo; Adenocarcinoma del Pulmón/mortalidad; Adenocarcinoma del Pulmón/patología; Anciano; Femenino; Humanos; Estimación de Kaplan-Meier; Pulmón/metabolismo; Neoplasias Pulmonares/mortalidad; Neoplasias Pulmonares/patología; Masculino; Persona de Mediana Edad; Estadificación de Neoplasias; Pronóstico; Mapas de Interacción de Proteínas; Proteómica; Riesgo

Palabras clave

high-risk subtype; low-risk subtype; lung adenocarcinoma; prognosis; proteomics

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Biomarcadores de Tumor / Adenocarcinoma del Pulmón / Neoplasias Pulmonares Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Mol Cell Proteomics Asunto de la revista: BIOLOGIA MOLECULAR / BIOQUIMICA Año: 2021 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google